School of Medicine
Showing 181-190 of 1,299 Results
-
Calvin Santiago, MD, FRCPC, MSc (he/him)
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Santiago is a board-certified neurologist with Stanford Health Care. He is a clinical assistant professor in the Department of Neurology and Neurological Sciences, Division of Comprehensive Neurology at Stanford University School of Medicine.
Dr. Santiago diagnoses and treats a wide range of neurological conditions, including headache, epilepsy, memory disorders, movement disorders, and neuropathy. He has a special focus on improving access to neurological care, including reducing patient wait times and directing patients to the most appropriate care provider by streamlining physician referrals. He also provides LGBTQ+ care.
His research interests include executive functioning and processing speed in older adults with coronary artery disease and using CT angiography in patients with acute ischemic stroke and transient ischemic attack. He has also researched speech-language changes in patients with mild cognitive impairment and Alzheimer’s disease.
Dr. Santiago has published in multiple peer-reviewed journals, including Alzheimer’s Research & Therapy, Alzheimer’s & Dementia, and Cureus: Journal of Medical Science. He has presented to his peers at national and regional meetings, including the Society of Biological Psychiatry Annual Meeting, History of Medicine Days at the University of Calgary, and the Advanced Learning in Palliative Medicine Conference at the University of Toronto.
Dr. Santiago is a member of the American Academy of Neurology, Canadian Neurological Sciences Foundation, and Ontario Medical Association. -
Christine Santiago
Clinical Assistant Professor, Medicine
BioDr. Christine Santiago, M.D., M.P.H. is a Clinical Assistant Professor in the Stanford Division of Hospital Medicine, dedicated to improving healthcare access and equity. Dr. Santiago graduated cum laude with an M.D. from Harvard Medical School and completed an M.P.H. in Health Policy and Management at the University of California, Berkeley. She then completed her Internal Medicine Residency at Stanford University, where she also served as Chief Resident.
Dr. Santiago has been a driving force behind several innovative curricular developments and community partnership initiatives. She co-founded and serves as the faculty director of the Stanford Health Equity, Advocacy, and Research Program. This program's mission is to train resident physicians to become leaders in health equity, equipped to serve their local communities effectively. She also co-founded the Hospital Medicine Health Equity Committee within Stanford's Division of Hospital Medicine, creating a structured platform for collaboration, idea sharing, and integration of health equity principles into various quality, research, and administrative initiatives. Furthermore, she has pioneered educational programs such as the Street Medicine Rotation, LGBTQ+ Clinical Rotation, and the Re-entry Medicine Rotation, creating significant opportunities for residents to gain invaluable experience in diverse healthcare settings.
With a strong focus on health equity and healthcare access, Dr. Santiago has been actively involved in mentoring programs and has received numerous accolades, including the SHC Medical Staff Award for Diversity, Equity, and Inclusion and the Inspiring Early Academic Career Award. Her research and quality improvement initiatives, particularly in the realms of health equity and patient care optimization, highlight her unwavering commitment to creating a more inclusive and effective healthcare system. -
Matteo Santoro Pharm.D., Ph.D.
Postdoctoral Scholar, Pathology
BioDr. Santoro joined Shamloo’s lab in March 2021 focusing his research on Parkinson’s disease, neuronal vulnerability, and identification of therapeutic markers in relation to α-synucleinopathies. Prior to his arrival at Stanford, he held a position as a clinical monitor at Syneos Health where he gained key knowledge needed to translate lab-based findings into clinical and commercial applications. Previously, Dr. Santoro held a postdoctoral position at the University of Aberdeen (Scotland, UK) working on amyloid-beta extracts from Alzheimer’s disease patients. During his postdoctoral research, Dr. Santoro designed and optimized a cost-effective and rapid assay for the measurement of toxic amyloid-beta species in human biofluids. In 2017, he obtained his Ph.D. (4-year program) at the University of Aberdeen on Parkinson’s disease (PD), immunology, and behavior. The major findings Ph.D. findings were the following: 1) the characterization of a small protein called HMGB1 as an inflammatory mediator in PD; 2) the motor and non-motor behavioral characterization of three neurotoxin based mouse models of PD, 3) the characterization of the innate immune response in PD through the toll-like receptor signaling pathways 4) evaluation of the effects of chronic systemic inflammation on both resident and infiltrating immune cells in the CNS. In 2012 Dr. Santoro attained his Pharm.D. in chemistry and pharmaceutical technology (5-year program) at the University of Calabria (Italy) during which he undertook an internship at the King’s College London (SGDP Centre) and worked for over a year on a rat model of stroke.
